US 11026920
Use of NK-1 receptor antagonist serlopitant in pruritus
granted A61KA61K31/403A61K31/4035
Quick answer
US patent 11026920 (Use of NK-1 receptor antagonist serlopitant in pruritus) held by Vyne Therapeutics Inc. expires Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Vyne Therapeutics Inc.
- Grant date
- Tue Jun 08 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jun 03 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61K, A61K31/403, A61K31/4035, A61K45/06, A61K47/10